Apotex Inc. is a leading Canadian pharmaceutical company delivering high-quality, affordable generic and innovative medicines to global markets, with a strong presence in the US and over 115 countries.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Apotex has recently focused on expanding its biosimilars portfolio, optimizing supply chain operations, and launching new generic products to meet evolving healthcare demands.
Expansion of manufacturing and distribution facilities in North America and India
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Apotex Inc. develops, manufactures, and distributes a broad portfolio of generic pharmaceuticals, biosimilars, and consumer health products. With state-of-the-art facilities in Canada, the US, India, and other regions, Apotex delivers over 1,000 products across various therapeutic classes, including cardiovascular, CNS, and pain management. The company is customer-centric, focusing on supply chain efficiency and global quality standards. Apotex reinvests heavily in research and development, driving innovation in drug delivery and biosimilars.
Toronto, Ontario, Canada
1974
Private company
